Immunobiologic agents for the treatment of psoriasis - Clinical research delivers new hope for patients with psoriasis

被引:7
作者
Gottlieb, A [1 ]
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Clin Res Ctr, New Brunswick, NJ 08901 USA
关键词
D O I
10.1001/archderm.139.6.791
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:791 / 793
页数:3
相关论文
共 31 条
  • [1] CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris
    Abrams, JR
    Lebwohl, MG
    Guzzo, CA
    Jegasothy, BV
    Goldfarb, MT
    Goffe, BS
    Menter, A
    Lowe, NJ
    Krueger, G
    Brown, MJ
    Weiner, RS
    Birkhofer, MJ
    Warner, GL
    Berry, KK
    Linsley, PS
    Krueger, JG
    Ochs, HD
    Kelley, SL
    Kang, SW
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (09) : 1243 - 1252
  • [2] Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells
    Abrams, JR
    Kelley, SL
    Hayes, E
    Kikuchi, T
    Brown, MJ
    Kang, SW
    Lebwohl, MG
    Guzzo, CA
    Jegasothy, BV
    Linsley, PS
    Krueger, JG
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (05) : 681 - 693
  • [3] IL-10 is a key cytokine in psoriasis -: Proof of principle by IL-10 therapy:: A new therapeutic approach
    Asadullah, K
    Sterry, W
    Stephanek, K
    Jasulaitis, D
    Leupold, M
    Audring, H
    Volk, HD
    Döcke, WD
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) : 783 - 794
  • [4] Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
    Chaudhari, U
    Romano, P
    Mulcahy, LD
    Dooley, LT
    Baker, DG
    Gottlieb, AB
    [J]. LANCET, 2001, 357 (9271) : 1842 - 1847
  • [5] Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes
    Ellis, CN
    Krueger, GG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (04) : 248 - 255
  • [6] SEVERE PSORIASIS - ORAL THERAPY WITH A NEW RETINOID
    FREDRIKSSON, T
    PETTERSSON, U
    [J]. DERMATOLOGICA, 1978, 157 (04): : 238 - 244
  • [7] Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis
    Gottlieb, A
    Krueger, JG
    Bright, R
    Ling, M
    Lebwohl, M
    Kang, S
    Feldman, S
    Spellman, M
    Wittkowski, K
    Ochs, HD
    Jardieu, P
    Bauer, R
    White, M
    Dedrick, R
    Garovoy, M
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (03) : 428 - 435
  • [8] Recombinantly engineered human proteins: Transforming the treatment of psoriasis
    Gottlieb, AB
    Bos, JD
    [J]. CLINICAL IMMUNOLOGY, 2002, 105 (02) : 105 - 116
  • [9] Gottlieb AB, 2002, J INVEST DERMATOL, V119, P234
  • [10] Gottlieb AB, 2001, ARTHRITIS RHEUM, V44, pS91